Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-06 Sale |
2025-01-06 8:35 pm |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
21,200 | $14.92 | $316,391 | 80,501 (Direct) |
View |
2024-01-05 Sale |
2024-01-08 6:01 pm |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
9,799 | $10.79 | $105,699 | 191,701 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-10 Option Award |
2025-01-10 6:07 pm |
N/A 2035-01-09 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
132,000 | $0 | 132,000 (Direct) |
View |
2025-01-06 Exercise |
2025-01-06 8:35 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
37,166 | $0 | 80,501 (Direct) |
View |
2024-01-05 Exercise |
2024-01-08 6:01 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
17,166 | $0 | 191,701 (Direct) |
View |
2024-01-05 Option Award |
2024-01-08 6:01 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
150,000 | $0 | 191,701 (Direct) |
View |
2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
129,000 | $0 | 129,000 (Direct) |
View |
2022-07-18 Option Award |
2022-07-19 9:05 pm |
N/A 2032-07-17 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |